Viral specific cytotoxic T cells inhibit the growth of TfR-expressing tumor cells with antibody targeted viral peptide/HLA-A2 complex.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2010.03.008PMID 20406704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma

  2008cited by this paper
• Transferrin receptor expression in reactive and neoplastic lesions of lymphnodes.

  2007cited by this paper
• Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2

  2007cited by this paper
• The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia

  2007cited by this paper
• Transferrin receptor 2 is frequently expressed in human cancer cell lines.

  2007cited by this paper
• Selective antibody‐mediated targeting of class I MHC to EGFR‐expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo

  2007cited by this paper
• Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase.

  2005cited by this paper
• Establishment of a transplantable human myeloid BALB/c nude mouse model.

  2005cited by this paper
• Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase

  2005cited by this paper
• Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.

  2004cited by this paper
• A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients

  2004cited by this paper
• T cell killing does not require the formation of a stable mature immunological synapse

  2004cited by this paper
• The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope1

  2004cited by this paper
• Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo

  2004cited by this paper
• Epstein–Barr virus: 40 years on

  2004cited by this paper
• An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells

  2002cited by this paper
• Recruitment of CTL Activity by Tumor-Specific Antibody-Mediated Targeting of Single-Chain Class I MHC-Peptide Complexes1

  2002cited by this paper
• Anti‐viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted hla class I/peptide complexes in scid mice

  2002cited by this paper
• Phenotypic and Functional Heterogeneity of EBV Epitope-Specific CD8+ T Cells1

  2002influential reference
• Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers

  2001cited by this paper
• MHC antigens and tumor escape from immune surveillance.

  2001cited by this paper
• Exogenous Peptides Presented by Transporter Associated with Antigen Processing (TAP)-Deficient and TAP-Competent Cells: Intracellular Loading and Kinetics of Presentation1

  2001cited by this paper
• Antibody-cytokine fusion proteins for the therapy of cancer.

  2001cited by this paper
• Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy.

  2001cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor

  2000cited by this paper
• Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes

  2000cited by this paper
• Recombinant human single‐chain MHC‐peptide complexes made from E. coli by in vitro refolding: functional single‐chain MHC‐peptide complexes and tetramers with tumor associated antigens

  2000cited by this paper
• Antibody‐conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes

  2000cited by this paper
• Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells1

  2000cited by this paper
• Monoclonal antibody therapy for solid tumors.

  2000cited by this paper
• Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma.

  2000cited by this paper
• Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.

  2000cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Monoclonal Antibodies in Cancer Therapy

  1996cited by this paper
• Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).

  1995cited by this paper
• Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope

  1994influential reference
• Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide‐stabilized anti‐TAC Fv fragment and truncated pseudomonas exotoxin

  1994cited by this paper
• Monoclonal antibodies in cancer therapy.

  1993cited by this paper
• Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials

  1993cited by this paper
• HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

  1992cited by this paper
• B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.

  1991cited by this paper
• Presentation of viral antigen controlled by a gene in the major histocompatibility complex

  1990cited by this paper
• The human HLA specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the α2 domain of murine H-2Db

  1986cited by this paper
• Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

  1981cited by this paper
• Mechanisms of immune lysis. II. CTL-induced nuclear disintegration of the target begins within minutes of cell contact.

  1980cited by this paper

• Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges

  2021cites this paper
• Establishment of a hTfR mAb-functionalized HPPS theranostic nanoplatform

  2020cites this paper
• The Inhibitory Effect of 6-Gingerol on Ubiquitin-Specific Peptidase 14 Enhances Autophagy-Dependent Ferroptosis and Anti-Tumor in vivo and in vitro

  2020cites this paper
• Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor

  2019cites this paper
• Oestrone‐targeted liposomes for mitoxantrone delivery via oestrogen receptor – synthesis, physicochemical characterization and in‐vitro evaluation

  2017cites this paper
• Endocytosis of a Functionally Enhanced GFP-Tagged Transferrin Receptor in CHO Cells

  2015cites this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012influential citation